Clinical Trial Update: Co-administration of Meningococcal Vaccine GSK134612 and Pneumococcal Vaccine GSK1024850A vs Individual Administration [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating co-administration of GSK134612 meningococcal vaccine with GSK1024850A pneumococcal vaccine versus separate administration; results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease

Drugs mentioned

• GSK1024850A pneumococcal vaccine (Pneumococcal vaccine)
• GSK134612 meningococcal vaccine (Meningococcal vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Meningococcal | Phase 3 | Status: COMPLETED | Results posted: 2018-05-09